Target intelligence / Profile preview

DENR pseudogene 3 (DENRP3)

Target
DENRP3
Molecular classification
Other (Pseudogene)
01

Overview

DENR pseudogene 3 is a processed pseudogene of the Density Regulated Re-Initiation And Release Factor (DENR) gene. As a pseudogene, DENRP3 does not encode a functional protein and has no known biological activity; its sequence is homologous to the functional DENR gene. Pseudogenes in general can occasionally function as regulatory noncoding RNAs, influencing gene expression through various post-transcriptional mechanisms such as microRNA sponging or competing endogenous RNA activity, but there is no data supporting this function for DENRP3 specifically. Because it is a pseudogene rather than an active receptor, enzyme, transporter, or other actionable molecular target, DENRP3 is not relevant to therapeutic intervention or drug discovery efforts. In summary, DENRP3 is a pseudogene with no documented functional, pharmacological, or disease-relevant roles, and should not be classified as a target or actionable receptor/enzyme/transporter.

Other names
DENR pseudogene 3DENRP3
02

Mechanism of action

Not applicable (no known protein product or established mechanism)

03

Biological functions

Other (no confirmed protein coding, may have a role at the RNA level as a non-coding RNA, but specific function is not documented)
04

Disease associations

Other (no specific disease associations for DENRP3 reported; some pseudogenes regulate disease genes, but this has not been shown for DENRP3)
05

Safety considerations

None relevant (not a therapeutic target, no safety profile required)

Beyond the preview

Go deeper on DENR pseudogene 3 (DENRP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DENR pseudogene 3 (DENRP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call